<bill session="116" type="s" number="3092" updated="2022-10-28T01:46:15Z">
  <state datetime="2019-12-18">REFERRED</state>
  <status>
    <introduced datetime="2019-12-18"/>
  </status>
  <introduced datetime="2019-12-18"/>
  <titles>
    <title type="display">Expanding Access to Low-Cost Generics Act of 2019</title>
    <title type="short" as="introduced">Expanding Access to Low-Cost Generics Act of 2019</title>
    <title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="S001203"/>
  <cosponsors>
    <cosponsor bioguide_id="B001310" joined="2019-12-18"/>
  </cosponsors>
  <actions>
    <action datetime="2019-12-18">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-12-18" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Civil actions and liability"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Intellectual property"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2021-09-13T18:46:41Z" status="Introduced in Senate">Expanding Access to Low-Cost Generics Act of 2019

This bill modifies the 180-day exclusivity period for certain generic drug manufacturers.</summary>
</bill>
